Christy L. Ludlow

Christy L. Ludlow

Auto-generated profile, based on publicly available information

Christy L. Ludlow

James Madison University

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2003 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
IPImke Puls
Imke Puls
CJCatherine Jonnakuty
Catherine Jonnakuty
BLBernadette H. LaMonte
Bernadette H. LaMonte
EHErika L.F. Holzbaur
Erika L.F. Holzbaur
MTMariko Tokito
Mariko Tokito
KFKenneth H. Fischbeck
Kenneth H. Fischbeck

6 May 2008 in Neurology
Verified
Journal Article
Closed access
PDF file
DSD. M. Simpson
D. M. Simpson
ABA. Blitzer
A. Blitzer
ABA. Brashear
A. Brashear
CCC. Comella
C. Comella
RDR. Dubinsky
R. Dubinsky
YSY. So
Y. So
Objective: To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of movement disorders. Methods: A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and selected movement disorders. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (Class I–IV). Results: The highest quality literature available for the respective indications was as follows: blepharospasm (two Class II studies); hemifacial spasm (one Class II and one Class III study); cervical dystonia (seven Class I studies); focal upper extremity dystonia (one Class I and three Class II studies); focal lower extremity dystonia (one Class II study); laryngeal dystonia (one Class I study); motor tics (one Class II study); and upper extremity essential tremor (two Class II studies). Recommendations: Botulinum neurotoxin should be offered as a treatment option for the treatment of cervical dystonia (Level A), may be offered for blepharospasm, focal upper extremity dystonia, adductor laryngeal dystonia, and upper extremity essential tremor (Level B), and may be considered for hemifacial spasm, focal lower limb dystonia, and motor tics (Level C). While clinicians9 practice may suggest stronger recommendations in some of these indications, evidence-based conclusions are limited by the availability of data.

1 August 1980 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
JRJudith L. Rapoport
Judith L. Rapoport
MBMonte S. Buchsbaum
Monte S. Buchsbaum
HWHerbert Weingartner
Herbert Weingartner
TZTheodore P. Zahn
Theodore P. Zahn
CLChristine Ludlow
Christine Ludlow
EMEdwin J. Mikkelsen
Edwin J. Mikkelsen
• The effects of a single oral dose of dextroamphetamine sulfate on motor activity, vigilance, learning, and mood were compared for normal and hyperactive prepubertal boys and normal college-aged men using a double-blind crossover design. Both groups of boys and men showed decreased motor activity, increased vigilance, and improvement on a learning task after taking the stimulant drug. The men reported euphoria, while the boys reported only feeling "tired" or "different" after taking the stimulant. It is not clear whether this difference in effect on mood between adults and children is due to differing experience with drugs, ability to report affect, or a true pharmacologic age-related effect. While there were some quantitative differences in drug effects on motor activity and vigilance between these different groups, stimulants appear to act similarly on normal and hyperactive children and adults.

27 December 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GLGuida Landouré
Guida Landouré
AZAnselm A Zdebik
Anselm A Zdebik
TMTara L Martinez
Tara L Martinez
BBBarrington G Burnett
Barrington G Burnett
HSHoria C Stanescu
Horia C Stanescu
CSCharlotte J Sumner
Charlotte J Sumner
Charlotte Sumner and colleagues report that mutations in the ankyrin repeat region of TRPV4 cause Charcot-Marie-Tooth disease type 2C. Their functional studies indicate that the mutations result in increased channel activity. Charcot-Marie-Tooth disease type 2C (CMT2C) is an autosomal dominant neuropathy characterized by limb, diaphragm and laryngeal muscle weakness. Two unrelated families with CMT2C showed significant linkage to chromosome 12q24.11. We sequenced all genes in this region and identified two heterozygous missense mutations in the TRPV4 gene, C805T and G806A, resulting in the amino acid substitutions R269C and R269H. TRPV4 is a well-known member of the TRP superfamily of cation channels. In TRPV4-transfected cells, the CMT2C mutations caused marked cellular toxicity and increased constitutive and activated channel currents. Mutations in TRPV4 were previously associated with skeletal dysplasias. Our findings indicate that TRPV4 mutations can also cause a degenerative disorder of the peripheral nerves. The CMT2C-associated mutations lie in a distinct region of the TRPV4 ankyrin repeats, suggesting that this phenotypic variability may be due to differential effects on regulatory protein-protein interactions.

3 February 1978 in Science
Verified
Journal Article
Closed access
PDF file
JRJ L Rapoport
J L Rapoport
MBM S Buchsbaum
M S Buchsbaum
TZT P Zahn
T P Zahn
HWH Weingartner
H Weingartner
CLC Ludlow
C Ludlow
EME J Mikkelsen
E J Mikkelsen
The behavioral, cognitive, and electrophysiological effects of a single dose of dextroamphetamine (0.5 milligram per kilogram of body weight) or placebo was examined in 14 normal prepubertal boys (mean age, 10 years 11 months) in a double-blind study. When amphetamine was given, the group showed a marked decrease in motor activity and reaction time and improved performance on cognitive tests. The similarity of the response observed in normal children to that reported in children with "hyperactivity" or minimal brain dysfunction casts doubt on pathophysiological models of minimal brain dysfunction which assume that children with this syndrome have a clinically specific or "paradoxical" response to stimulants.

1 May 1997 in Brain
Verified
Journal Article
Open access
PDF file
ABA R Braun
A R Braun
MVM Varga
M Varga
SSS Stager
S Stager
GSGERALYN SCHULZ
GERALYN SCHULZ
SSS Selbie
S Selbie
CLC L Ludlow
C L Ludlow
To assess dynamic brain function in adults who had stuttered since childhood, regional cerebral blood flow (rCBF) was measured with H2O and PET during a series of speech and language tasks designed to evoke or attenuate stuttering. Speech samples were acquired simultaneously and quantitatively compared with the PET images. Both hierarchical task contrasts and correlational analyses (rCBF versus weighted measures of dysfluency) were performed. rCBF patterns in stuttering subjects differed markedly during the formulation and expression of language, failing to demonstrate left hemispheric lateralization typically observed in controls; instead, regional responses were either absent, bilateral or lateralized to the right hemisphere. Significant differences were detected between groups when all subjects were fluent-during both language formulation and non-linguistic oral motor tasks-demonstrating that cerebral function may be fundamentally different in persons who stutter, even in the absence of stuttering. Comparison of scans acquired during fluency versus dysfluency-evoking tasks suggested that during the production of stuttered speech, anterior forebrain regions-which play an a role in the regulation of motor function-are disproportionately active in stuttering subjects, while post-rolandic regions-which play a role in perception and decoding of sensory information-are relatively silent. Comparison of scans acquired during these conditions in control subjects, which provide information about the sensorimotor or cognitive features of the language tasks themselves, suggest a mechanism by which fluency-evoking maneuvers might differentially affect activity in these anterior and posterior brain regions and may thus facilitate fluent speech production in individuals who stutter. Both correlational and contrast analyses suggest that right and left hemispheres play distinct and opposing roles in the generation of stuttering symptoms: activation of left hemispheric regions appears to be related to the production of stuttered speech, while activation of right hemispheric regions may represent compensatory processes associated with attenuation of stuttering symptoms.